Nebulizer vs Handheld Therapy for COPD
(DELIVERY Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
Multi-site, randomized controlled trial to determine whether patients who report NO symptomatic benefit with their maintenance hand-held inhaler(s), benefit upon switching to nebulized therapy using comparable classes of medications.
Are You a Good Fit for This Trial?
This trial is for people with COPD who are currently using handheld inhalers for maintenance but do not feel any symptom relief from them. Participants should be adults and able to use either nebulizers or inhalers.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Trial Overview
The study compares two ways of taking regular COPD medication: continuing with handheld inhalers versus switching to a nebulizer that delivers similar medicines. Patients are randomly assigned to one group or the other.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Subjects continue with their current maintenance handheld inhaler regimen
Subjects switched to nebulized therapy using similar medication solutions
Find a Clinic Near You
Who Is Running the Clinical Trial?
COPD Foundation
Lead Sponsor
Theravance Biopharma
Industry Sponsor
Rick E. Winningham
Theravance Biopharma
Chief Executive Officer since 2014
Bachelor's degree in Economics from Southern Methodist University
Laurie Smaldone Alsup
Theravance Biopharma
Chief Medical Officer since 2018
MD from McGill University
Viatris Specialty LLC
Industry Sponsor
PARI Respiratory Equipment, Inc.
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.